Alpha Healthcare Acquisition Corp. III (ALPA) Stock Analysis

Alpha Healthcare Acquisition Corp. III (ALPA) Financial Services Profile

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) targeting a merger within the U.S. healthcare sector. Incorporated in 2021, the company seeks to identify and acquire a promising healthcare business, offering investors exposure to potential growth through a business combination.

What Is the Investment Thesis for ALPA?

Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to successfully identify and merge with a promising healthcare company. The company's market capitalization stands at $0.19 billion, reflecting investor expectations regarding its acquisition prospects. A key value driver is the management team's expertise in sourcing and executing healthcare deals. However, the company's negative profit margin of -199.6% underscores its current lack of operational revenue. The investment thesis hinges on the successful completion of a merger within the next 12-24 months, which would serve as a major catalyst. Failure to do so could lead to liquidation and loss of investment. The gross margin of 59.3% is not relevant until a merger target is acquired.

Based on FMP financials and quantitative analysis

ALPA Key Highlights

Market capitalization of $0.19 billion reflects investor sentiment regarding potential acquisition targets.

• Negative profit margin of -199.6% indicates the company's current lack of operating business and reliance on a future merger.
• Gross margin of 59.3% is not relevant until a merger target is acquired.
• The company operates as a SPAC, with its primary focus on identifying and merging with a healthcare business.
• No dividend yield, as the company is not generating revenue and is focused on completing an acquisition.

Who Are ALPA's Competitors?

ALPA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ALPA's Key Strengths?

Experienced management team with expertise in healthcare.

• Access to capital through public markets.
• Flexibility to pursue a wide range of healthcare businesses.
• Potential for high returns if a successful merger is completed.

What Are ALPA's Weaknesses?

Lack of operating history.

• Dependence on identifying and completing a successful merger.
• Competition from other SPACs.
• Risk of liquidation if a merger is not completed within the specified timeframe.

What Could Drive ALPA Stock Higher?

Announcement of a definitive merger agreement with a target healthcare company.

• Completion of the merger transaction, providing access to a revenue-generating business.
• Positive developments in the healthcare industry, such as new technologies and treatments.
• Successful integration of the acquired company and realization of synergies.

What Are the Key Risks for ALPA?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

• Failure to identify and complete a merger within the specified timeframe, leading to liquidation.
• Economic downturn impacting the healthcare industry and the value of potential merger targets.
• Changes in healthcare regulations negatively impacting the acquired company's business.
• Competition from other SPACs seeking to acquire healthcare companies.
• Integration challenges post-merger, hindering the realization of synergies.

What Are the Growth Opportunities for ALPA?

• Successful Merger Completion: The primary growth opportunity lies in successfully identifying and completing a merger with a high-growth potential healthcare company. The market size for healthcare acquisitions is substantial, with billions of dollars in deals occurring annually. A successful merger would provide Alpha Healthcare Acquisition Corp. III with a revenue-generating business and the potential for significant value creation for shareholders. The timeline for this opportunity is within the next 12-24 months, as SPACs typically have a limited timeframe to complete a merger.
• Operational Improvements Post-Merger: Once a merger is completed, there is an opportunity to improve the operational efficiency and profitability of the acquired company. This could involve streamlining operations, implementing new technologies, and expanding into new markets. The market size for operational improvements within the healthcare industry is significant, as many healthcare companies face challenges related to cost control and efficiency. The timeline for this opportunity is ongoing, as operational improvements can be implemented over several years.
• Strategic Acquisitions Post-Merger: After a successful initial merger, there is an opportunity to pursue strategic acquisitions to expand the company's market share and product offerings. The market size for healthcare acquisitions is substantial, with numerous companies seeking to grow through acquisitions. Strategic acquisitions could provide Alpha Healthcare Acquisition Corp. III with access to new technologies, markets, and customers. The timeline for this opportunity is medium-term, as it typically takes time to integrate an initial acquisition before pursuing additional deals.
• Expansion into New Geographies: There is an opportunity to expand the acquired company's operations into new geographic markets. The global healthcare market is vast and growing, with significant opportunities in emerging markets. Expanding into new geographies could provide Alpha Healthcare Acquisition Corp. III with access to new customers and revenue streams. The timeline for this opportunity is long-term, as it typically takes time to establish operations in new markets.
• Development of New Products and Services: There is an opportunity to develop new products and services to meet the evolving needs of the healthcare market. The healthcare industry is constantly innovating, with new technologies and treatments emerging regularly. Developing new products and services could provide Alpha Healthcare Acquisition Corp. III with a competitive advantage and the potential for significant revenue growth. The timeline for this opportunity is ongoing, as product development is a continuous process.

What Opportunities Does ALPA Have?

• Growing demand for healthcare services.
• Innovation in healthcare technology.
• Increasing number of private healthcare companies seeking to go public.
• Potential to create significant value through a successful merger.

What Are ALPA's Competitive Advantages?

• Management team's expertise in sourcing and executing healthcare deals.
• Access to capital through the public markets.
• Ability to provide a private company with a faster and less regulated path to the public market.

What Does ALPA Do?

Alpha Healthcare Acquisition Corp. III, incorporated in 2021 and based in New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and merge with a business in the healthcare industry within the United States. As a SPAC, Alpha Healthcare Acquisition Corp. III does not have significant ongoing operations of its own. Instead, it focuses on sourcing, acquiring, and managing a business through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company's strategy revolves around leveraging the expertise of its management team to identify a high-growth potential healthcare business and bring it to the public market. This approach allows investors to participate in the potential upside of the acquired company while mitigating some of the risks associated with early-stage investments. The success of Alpha Healthcare Acquisition Corp. III hinges on its ability to identify and execute a successful merger that creates value for its shareholders.

What Products and Services Does ALPA Offer?

• Identify potential merger targets in the healthcare industry.
• Conduct due diligence on potential merger targets.
• Negotiate merger agreements with target companies.
• Raise capital to fund the merger.
• Complete the merger transaction.
• Manage the acquired company post-merger.

How Does ALPA Make Money?

• Alpha Healthcare Acquisition Corp. III operates as a special purpose acquisition company (SPAC).
• The company raises capital through an initial public offering (IPO).
• The company uses the capital raised to acquire a private company in the healthcare industry.
• The acquired company becomes a publicly traded company through the merger with the SPAC.

What Industry Does ALPA Operate In?

Alpha Healthcare Acquisition Corp. III operates within the special purpose acquisition company (SPAC) segment of the financial services industry. SPACs have become a popular alternative to traditional IPOs, offering companies a faster and potentially less regulated path to the public market. The healthcare sector has been a particularly active area for SPAC mergers, driven by innovation, demographic trends, and increasing demand for healthcare services. The competitive landscape includes numerous SPACs seeking to acquire businesses in various sectors, including healthcare. The success of Alpha Healthcare Acquisition Corp. III depends on its ability to differentiate itself and secure a compelling merger target in a competitive market.

Who Are ALPA's Key Customers?

• Investors who participate in the IPO of Alpha Healthcare Acquisition Corp. III.
• The private company that is acquired by Alpha Healthcare Acquisition Corp. III.
• Shareholders of the merged company.

Company Profile

Alpha Healthcare Acquisition Corp. III operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Rajiv Sarman Shukla. ALPA has traded publicly since 2021.

ALPA Revenue & Earnings Trend

In Q2 2026, ALPA generated $396K in top-line revenue, marking a sequential increase of 1.1%. The company recorded a net loss of $1.9M, with diluted EPS of $-0.76. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Financial Services. Across the four most recent quarters, ALPA averaged $-1.18 in diluted EPS.

Return on equity for Alpha Healthcare Acquisition Corp. III stands at 107.4%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -28.1%, the inverse of the P/E and a quick read on earnings relative to price.

Alpha Healthcare Acquisition Corp. III's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ALPA Financials

ALPA Latest News

No recent news available for ALPA.

ALPA Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources